Cosmos Health Sees FY27 Revenue To Increase By 163%, From $59.35M In 2024 To $155.80M In 2027; Gross Profit To Grow By 653%, From $6.25M In 2024 To $47.06M In 2027; Gross Profit Margin To Expand By 1,970 Basis Points, From 10.50% In 2024 To 30.20% In...
Cosmos Health Sees FY27 Revenue To Increase By 163%, From $59.35M In 2024 To $155.80M In 2027; Gross Profit To Grow By 653%, From $6.25M In 2024 To $47.06M In 2027; Gross Profit Margin To Expand By 1,970 Basis Points, From 10.50% In 2024 To 30.20% In...
阿童木健康預計2027財年營業收入將增長163%，從2024年的5935萬增加到2027年的15580萬；毛利潤將增長653%，從2024年的625萬增加到2027年的4706萬；毛利潤率將擴大1970個點子，從2024年的10.50%增加到2027年的30.20%...
Cosmos Health Sees FY27 Revenue To Increase By 163%, From $59.35M In 2024 To $155.80M In 2027; Gross Profit To Grow By 653%, From $6.25M In 2024 To $47.06M In 2027; Gross Profit Margin To Expand By 1,970 Basis Points, From 10.50% In 2024 To 30.20% In 2027; Net Income To Increase By 402%, Reaching $20.44M In 2027, Compared To A Loss Of $6.76M In 2024; Adjusted EBITDA To Grow To $29.40M In 2027, From A Loss Of $1.21M In 2024.
Cosmos Health預計27財年收入將增長163％，從2024年的5,935萬美元增至2027年的1.558億美元；毛利增長653％，從2024年的625萬美元增至2027年的4706萬美元；毛利率將增長1970個點子，從2024年的10.50％增長到2027年的30.20％；淨收入將增長402％，2022年達到2044萬美元 7，相比之下，2024年的虧損爲676萬美元；調整後的息稅折舊攤銷前利潤將從2024年的121萬美元增至2027年的2940萬美元。
Updated Financial Guidance
更新的財務指導
We are pleased to see the pieces of our multi-year strategy coming together, which has made us confident in communicating our 2024-2027 guidance. By 2027, we anticipate substantial value creation by achieving the following:
我們很高興看到我們多年戰略的各個部分彙集在一起，這使我們有信心傳達2024-2027年的指導方針。到2027年，我們預計通過實現以下目標來創造可觀的價值：
Revenue to increase by 163%, from $59.35 million in 2024 to...
收入將增長163...
登入免費觀看全文
登入/註冊
熱門討論
特朗普2.0時代開啟，全球市場將如何演變？
🎙️討論： 1. 關稅政策將如何影響美股、黃金、比特幣等核心資產的走勢？ 2. 在此背景下，有哪些投資機會值得關注？你會如何佈局？
Moo Live
01/23 16:54
MicroStrategy 2024年第4季度業績電話會